Prenatal thyroid releasing hormone and thyroid releasing hormone plus dexamethasone lessen the survival of newborn rats during prolonged high O2 exposure

M. Rodriguez-Pierce, Ilene Sosenko, L. Frank

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Newborn rats prenatally treated with TRH or the combination of TRH+DEX have lower lung antioxidant enzyme activities at birth than control newborns but are able to induce an adaptive antioxidant enzyme response to hyperoxic exposure of similar or even greater magnitude compared to O2 control offspring. Because of this greater antioxidant enzyme response, we hypothesized that the hormonally pretreated newborns might demonstrate superior tolerance to prolonged high O2 exposure. However, when placed in >95% O2 at birth, the survival rates were consistently lower in the TRH- and TRH+DEX-treated pups at all time periods in hyperoxia from 9 d [control = 74 of 92 (80%); TRH+DEX = 32 of 47 (68%); TRH = 29 of 48 (60%); p < 0.05] to 14 d [control = 43 of 92 (47%); TRH+DEX = 11 of 47 (23%); TRH = nine of 48 (19%); (p < 0.05)]. Other evidence of poorer O2 tolerance in the prenatal hormone-treated pups included a greater incidence of intraalveolar edema and elevated lung conjugated dienes, an index of lipid peroxidation, at 3, 5, and 7 d of O2 exposure. There was also a persistent elevation in 3,5,3'-triiodo- L-thyronine and thyroxine serum levels in the 10-d-old TRH-treated offspring. We conclude that prenatal TRH treatment, possibly working through the secretion of 3,5,3'-triiodo-L-thyronine and thyroxine, has some important lasting postnatal effect (not completely reversed by dexamethasone) that predisposes newborn rats to greater O2 radical-induced lung sequelae of prolonged hyperoxic exposure.

Original languageEnglish
Pages (from-to)407-411
Number of pages5
JournalPediatric Research
Volume32
Issue number4
StatePublished - Jan 1 1992

Fingerprint

Thyroid Hormones
Thyronines
Dexamethasone
Antioxidants
Thyroxine
Lung
Enzymes
Hyperoxia
Birth Rate
Contraception
Lipid Peroxidation
Edema
Survival Rate
Hormones
Incidence
Serum
Therapeutics

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Prenatal thyroid releasing hormone and thyroid releasing hormone plus dexamethasone lessen the survival of newborn rats during prolonged high O2 exposure. / Rodriguez-Pierce, M.; Sosenko, Ilene; Frank, L.

In: Pediatric Research, Vol. 32, No. 4, 01.01.1992, p. 407-411.

Research output: Contribution to journalArticle

@article{5eba55662a524be7a3d93a6c3cea5223,
title = "Prenatal thyroid releasing hormone and thyroid releasing hormone plus dexamethasone lessen the survival of newborn rats during prolonged high O2 exposure",
abstract = "Newborn rats prenatally treated with TRH or the combination of TRH+DEX have lower lung antioxidant enzyme activities at birth than control newborns but are able to induce an adaptive antioxidant enzyme response to hyperoxic exposure of similar or even greater magnitude compared to O2 control offspring. Because of this greater antioxidant enzyme response, we hypothesized that the hormonally pretreated newborns might demonstrate superior tolerance to prolonged high O2 exposure. However, when placed in >95{\%} O2 at birth, the survival rates were consistently lower in the TRH- and TRH+DEX-treated pups at all time periods in hyperoxia from 9 d [control = 74 of 92 (80{\%}); TRH+DEX = 32 of 47 (68{\%}); TRH = 29 of 48 (60{\%}); p < 0.05] to 14 d [control = 43 of 92 (47{\%}); TRH+DEX = 11 of 47 (23{\%}); TRH = nine of 48 (19{\%}); (p < 0.05)]. Other evidence of poorer O2 tolerance in the prenatal hormone-treated pups included a greater incidence of intraalveolar edema and elevated lung conjugated dienes, an index of lipid peroxidation, at 3, 5, and 7 d of O2 exposure. There was also a persistent elevation in 3,5,3'-triiodo- L-thyronine and thyroxine serum levels in the 10-d-old TRH-treated offspring. We conclude that prenatal TRH treatment, possibly working through the secretion of 3,5,3'-triiodo-L-thyronine and thyroxine, has some important lasting postnatal effect (not completely reversed by dexamethasone) that predisposes newborn rats to greater O2 radical-induced lung sequelae of prolonged hyperoxic exposure.",
author = "M. Rodriguez-Pierce and Ilene Sosenko and L. Frank",
year = "1992",
month = "1",
day = "1",
language = "English",
volume = "32",
pages = "407--411",
journal = "Pediatric Research",
issn = "0031-3998",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Prenatal thyroid releasing hormone and thyroid releasing hormone plus dexamethasone lessen the survival of newborn rats during prolonged high O2 exposure

AU - Rodriguez-Pierce, M.

AU - Sosenko, Ilene

AU - Frank, L.

PY - 1992/1/1

Y1 - 1992/1/1

N2 - Newborn rats prenatally treated with TRH or the combination of TRH+DEX have lower lung antioxidant enzyme activities at birth than control newborns but are able to induce an adaptive antioxidant enzyme response to hyperoxic exposure of similar or even greater magnitude compared to O2 control offspring. Because of this greater antioxidant enzyme response, we hypothesized that the hormonally pretreated newborns might demonstrate superior tolerance to prolonged high O2 exposure. However, when placed in >95% O2 at birth, the survival rates were consistently lower in the TRH- and TRH+DEX-treated pups at all time periods in hyperoxia from 9 d [control = 74 of 92 (80%); TRH+DEX = 32 of 47 (68%); TRH = 29 of 48 (60%); p < 0.05] to 14 d [control = 43 of 92 (47%); TRH+DEX = 11 of 47 (23%); TRH = nine of 48 (19%); (p < 0.05)]. Other evidence of poorer O2 tolerance in the prenatal hormone-treated pups included a greater incidence of intraalveolar edema and elevated lung conjugated dienes, an index of lipid peroxidation, at 3, 5, and 7 d of O2 exposure. There was also a persistent elevation in 3,5,3'-triiodo- L-thyronine and thyroxine serum levels in the 10-d-old TRH-treated offspring. We conclude that prenatal TRH treatment, possibly working through the secretion of 3,5,3'-triiodo-L-thyronine and thyroxine, has some important lasting postnatal effect (not completely reversed by dexamethasone) that predisposes newborn rats to greater O2 radical-induced lung sequelae of prolonged hyperoxic exposure.

AB - Newborn rats prenatally treated with TRH or the combination of TRH+DEX have lower lung antioxidant enzyme activities at birth than control newborns but are able to induce an adaptive antioxidant enzyme response to hyperoxic exposure of similar or even greater magnitude compared to O2 control offspring. Because of this greater antioxidant enzyme response, we hypothesized that the hormonally pretreated newborns might demonstrate superior tolerance to prolonged high O2 exposure. However, when placed in >95% O2 at birth, the survival rates were consistently lower in the TRH- and TRH+DEX-treated pups at all time periods in hyperoxia from 9 d [control = 74 of 92 (80%); TRH+DEX = 32 of 47 (68%); TRH = 29 of 48 (60%); p < 0.05] to 14 d [control = 43 of 92 (47%); TRH+DEX = 11 of 47 (23%); TRH = nine of 48 (19%); (p < 0.05)]. Other evidence of poorer O2 tolerance in the prenatal hormone-treated pups included a greater incidence of intraalveolar edema and elevated lung conjugated dienes, an index of lipid peroxidation, at 3, 5, and 7 d of O2 exposure. There was also a persistent elevation in 3,5,3'-triiodo- L-thyronine and thyroxine serum levels in the 10-d-old TRH-treated offspring. We conclude that prenatal TRH treatment, possibly working through the secretion of 3,5,3'-triiodo-L-thyronine and thyroxine, has some important lasting postnatal effect (not completely reversed by dexamethasone) that predisposes newborn rats to greater O2 radical-induced lung sequelae of prolonged hyperoxic exposure.

UR - http://www.scopus.com/inward/record.url?scp=0026714841&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026714841&partnerID=8YFLogxK

M3 - Article

VL - 32

SP - 407

EP - 411

JO - Pediatric Research

JF - Pediatric Research

SN - 0031-3998

IS - 4

ER -